Expression of the multidrug resistance-associated protein gene in refractory lymphoma: Quantitation by a validated polymerase chain reaction assay

Blood

Volumn 89, Issue 10, 1997, Pages 3795-3800

  Zhan, Zhirong ^a   Sandor, Victor A ^a   Gamelin, Erick ^a   Regis, Joanna ^a   Dickstein, Bruce ^a   Wilson, Wyndham ^a   Fojo, Antonio T ^a   Bates, Susan E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P;

ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030915104     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.10.3795     Document Type: Article

References (32)

1. Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen D-W, Gottesman MM, Pastan I: Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83:4538, 1986
2. Endicott JA, Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137, 1989
3. Harrison DJ: Molecular mechanisms of drug resistance in tumors. J Pathol 175:7, 1995
4. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650, 1993
5. Slovak ML, Ho JP, Bhardwaj G, Kurz EU, Deeley RG, Cole SPC: Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res 53:3221, 1993
6. Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SP, Deeley RG: Characterization of the M(r) 190,000 multidrug resistance protein. Cancer Res 55:102, 1995
7. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM. Deeley RG: Pharmacological characterization of multidrug resistant. Cancer Res 54:5902, 1994
8. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG: Overexpression of multidrug resistance associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54:357, 1994
9. Zaman GJR, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P: The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91:8822, 1994
10. Bhalla K, Hindenberg A, Taub RN, Grant S: Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res 45:3657, 1985
11. Doyle LA, Ross DD, Ordonez JV, Yang W, Gao Y, Tong Y, Belani CP, Gutheil JC: An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. Br J Cancer 72:535, 1995
12. Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH: Multidrug resistance-associated protein gene Overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 54:152, 1994
13. Versantvoort CHM, Broxterman HJ, Pinedo HM, de Vries EGE, Feller N, Kuiper CM, Lankelma J: Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Res 52:17, 1992
14. Sognier MA, Zhang Y, Eberle R, Sweet KM, Altenberg GA, Belli J: Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100). Biochem Pharmacol 48:391, 1995
15. Schneider E, Yamazaki H, Sinha BK, Cowan KH: Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. Br J Cancer 71:738, 1995
16. Feller N, Broxterman HJ, Wahrer DCR, Pinedo HM: ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): No inhibition by intracellular glutathione depletion. FEBS Lett 368:385, 1995
17. Versantvoort CHM, Broxterman HJ, Lankelma J, Feller N, Pinedo HM: Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 48:1129, 1994
18. Gekeler V, Boer R, Ise W, Sanders KH, Schachtele C, Beck J: The specific bisindoylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem Biophys Res Commun 206:119, 1995
19. Gekeler V, Ise W, Sanders KH, Ulrich WR, Beck J: The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Commun 208:345, 1995
20. Ross DD, Doyle LA, Schiffer CA, Lee EJ, Grant CE, Cole SP, Deeley RG, Yang W, Tong Y: Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Leukemia 10:48, 1996
21. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL, Haber M: Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 334:231. 1996
22. Schneider E, Cowan KH, Bader H, Toomey S, Schwartz GN, Karp JE, Burke PJ, Kaufmann SH: Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 85:186, 1995
23. Hart SM, Ganeshaguru K, Hoffbrand AV, Prentice HG, Mehta AB: Expression of the multidrug resistance-associated protein (MRP). Leukemia 8:2163, 1994
24. Sugawara I, Masunaga A, Itoyama S, Sumizawa T, Akiyama S, Yamashita T: Expression of multidrug resistance-associated protein (MRP) in thyroid cancers. Cancer Lett 95:135, 1995
25. Ota E, Abe Y, Oshika Y, Ozeki Y, Iwasaki M, lnoue H, Yamazaki H, Ueyama Y, Takagi K, Ogata T: Expression of the multidrug resistance-associated protein (MRP) gene in non-small cell lung cancer. Br J Cancer 72:550, 1995
26. Zhou DC, Zittoun R, Marie JP: Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia 9:1661, 1995
27. Kuss BJ, Deeley RG, Cole SP, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA: Deletion of gene for multidrug resistance in acute myeloid leukemia with inversion of chromosome 16: prognostic implications. Lancet 343:1531, 1994
28. Wilson WH, Bates SE, Fojo AT, Bryant G, Zhan Z, Regis J, Wittes RE, Jaffe ES, Steinberg SM, Herdt J, Chabner BA: Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. J Clin Oncol 13:1995, 1995
29. Murphy LD, Herzog CE, Rudick JB, Fojo AJ, Bates SE: Use of the polymerase chain reaction in the quantitation of MDR-1 gene expression. Biochemistry 29:10351, 1990
30. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1987
31. Kang YK, Zhan Z, Regis J, Robey R, Meadows B, Dickstein B, Lee JS, Otsuki T, Stetler-Stevenson MA, Jaffe ES, Solomon D, Wilson WH, Fojo A, Bates SE: Expression of MDR-1 in refractory lymphoma: Quantitation by polymerase chain reaction and validation of the assay. Blood 86:1515, 1995
32. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987